SOURCE: The Medicines Company

The Medicines Company

February 06, 2014 17:48 ET

The Medicines Company to Host Acute Cardiovascular Care Investor and Analyst Meeting on March 7

Webcast to Be Held at Noon Eastern Time

PARSIPPANY, NJ--(Marketwired - Feb 6, 2014) -  The Medicines Company (NASDAQ: MDCO) has scheduled an acute cardiovascular care investor and analyst meeting for Friday, March 7, 2014 at the Company's Global Center 1 at 8 Sylvan Way in Parsippany, NJ. The "deep-dive" event is being hosted to review The Medicines Company's acute cardiovascular care portion of its portfolio.

The meeting will be webcast at noon eastern time and can be accessed via The Medicines Company website at www.themedicinescompany.com. Investors and Analysts interested in registration information can request by emailing investor.relations@themedco.com.

About The Medicines Company
The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.

Contact Information

  • Contact:

    Neera Dahiya Ravindran, MD
    Vice President, Investor Relations & Strategic Planning
    The Medicines Company
    +1 (973) 290-6044
    neera.ravindran@themedco.com